EpiBone, a NYC-based regenerative medicine company, raised an undisclosed amount in funding.
The round was led by Kendall Capital Partners, with participation from LifeSpan Vision Ventures, EMV Capital, and others.
The company intends to use the funds to accelerate its ongoing pipeline development efforts.
Led by CEO Dr. Nina Tandon, EpiBone is a regenerative medicine company focused on skeletal reconstruction. Its technologies represent advanced treatment modalities that leverage autologous and allogeneic stem cells, 3D bioprinting, and bioreactor technology to provide personalized, effective solutions for bone and osteochondral reconstruction.
The company is currently developing a pipeline of bone, cartilage, and other skeletal tissue products.
FinSMEs
11/11/2024